I 
117TH CONGRESS 
2D SESSION 
H. R. 6813 
To direct the Secretary of Health and Human Services, acting through 
the Director of the National Institutes of Health, to conduct a study 
on the neurological impacts of COVID–19 on individuals with a neuro-
logical disease. 
IN THE HOUSE OF REPRESENTATIVES 
FEBRUARY 22, 2022 
Mr. KEATING introduced the following bill; which was referred to the 
Committee on Energy and Commerce 
A BILL 
To direct the Secretary of Health and Human Services, 
acting through the Director of the National Institutes 
of Health, to conduct a study on the neurological impacts 
of COVID–19 on individuals with a neurological disease. 
Be it enacted by the Senate and House of Representa-
1
tives of the United States of America in Congress assembled, 
2
SECTION 1. STUDY ON THE NEUROLOGICAL IMPACTS OF 
3
COVID–19 ON INDIVIDUALS WITH A NEURO-
4
LOGICAL DISEASE. 
5
(a) STUDY.—The Secretary of Health and Human 
6
Services, acting through the Director of the National In-
7
stitutes of Health, shall conduct a study on the neuro-
8
VerDate Sep 11 2014 
05:39 Apr 07, 2022
Jkt 029200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6201
E:\BILLS\H6813.IH
H6813
pbinns on DSKJLVW7X2PROD with BILLS
2 
•HR 6813 IH
logical impacts of COVID–19 on individuals with a neuro-
1
logical disease. 
2
(b) REPORT.—Not later than 120 days after the date 
3
of enactment of this Act, the Secretary of Health and 
4
Human Services shall complete the study under subsection 
5
(a) and submit to the Congress a report on the results 
6
of such study. 
7
Æ 
VerDate Sep 11 2014 
05:39 Apr 07, 2022
Jkt 029200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6301
E:\BILLS\H6813.IH
H6813
pbinns on DSKJLVW7X2PROD with BILLS
